Notice Filed with SOS |
10/15/2022 |
Rule |
ProposedRuleAttach2022-00660.doc
|
Statutory Authority |
Sections 12-20-204(1), 12-30-109(6), 12-240-106(1)(a), and 24-4-103, C.R.S. |
Description of Subjects/Issues |
The purpose of this Permanent Rulemaking Hearing is for the Colorado Medical Board to consider adopting revisions to Rule 180 (3 CCR 713-49), to address concerns from the Office of Legislative Legal Services and implement Colorado House Bill 22-1115 (Concerning the Prescription Drug Monitoring Program). |
Purpose/Objective of Rule |
The purpose of the Colorado Medical Board adopting revisions to Rule 180 (3 CCR 713-49), was to address concerns from the Office of Legislative Legal Services and implement Colorado House Bill 22-1115 (Concerning the Prescription Drug Monitoring Program). |
Submitted in response to issues raised by COLS/OLLS? |
Yes
|
Is this rule adopted in response to recent legislation? |
Yes
|
Recent legislation bill number |
HB22-1115
|
Hearing Date |
11/17/2022 |
Hearing Time |
01:00 PM |
Hearing Location |
Webinar Only: https://us06web.zoom.us/webinar/register/WN_osUCyJRfSlqkjeeIFYx7yg |
Contact Name |
Elena M. Kemp |
Contact Title |
Regulatory Coordinator |
Contact Telephone |
303-894-7426 |
Contact email |
Dora_dpo_rulemaking@state.co.us |